NCT02154139View on ClinicalTrials.gov

"Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"

CompletedOBSERVATIONAL
Enrollment

651

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Breast Cancer
Interventions
DRUG

Leuprorelin acetate

Leuprorelin acetate SR 11.25 mg for injection

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02154139 - "Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)" | Biotech Hunter | Biotech Hunter